Form EFFECT Cocrystal Pharma, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 1, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Litecoin Price Prediction: LTC Holds Above $70 as $100 Remains a Bull Scenario and Remittix Opens BINANCE500
- Sui Price Prediction: Short Squeeze Sends SUI Flying as AlphaPepe’s 5th CEX Buzz Starts Heating Up
- Crypto News Today: BlackRock Portfolios Move Onchain as Remittix Opens the BINANCE500 Rewards Window
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share